Finally, following recent concerns by regulatory agencies regarding a potential increase in suicidal behavior associated with GLP-1RAs 206 , we found 1 recent pharmacovigilance report showing 0.6% suicidal events among 41,236 safety reports for these medications 207 and an emulated target trial of 86,418 older adults with T2DM that did not identify any difference in suicidal ideation or behavior between GLP-1RAs and other antidiabetic medications over 1.5 years 208
Psychoneuroendocrinology 38 , 12591270 (2013)
This is your #1 tool to protect muscle and metabolism
Clearance Total body clearance was found to be a mean of 4L/h
However, injectable semaglutide (2.4 mg) still produces greater absolute weight loss (14.9% vs 12.4%) and has proven cardiovascular benefit from SELECT, plus years of real-world safety data
Although many medications dont require dose adjustments with GLP-1 therapy, individual circumstances often call for tailored approaches to address specific risks